You Position: Home > Journal issue
Clinical Oncology and Cancer Research
2024:
2023:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2022:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2021:
2020:
2019:
2018:
2017:
2016:
2015:
2014:
2013:
2012:
2011:
2010:
2009:
2008:
2007:
2006:
2005:
Clinical Oncology and Cancer Research
1
Role of the mechanical microenvironment in cancer development and progression
Cancer Biology & Medicine, Volume 17, Issue 2,2020, Pages 282-292, doi:10.20892/j.issn.2095-3941.2019.0437
2
Clinical study of apatinib in the treatment of stage Ⅳ osteogenic sarcoma after failure of chemotherapy
Cancer Biology & Medicine, Volume 17, Issue 2,2020, Pages 501-512, doi:10.20892/j.issn.2095-3941.2019.0397
3
Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression
Cancer Biology & Medicine, Volume 17, Issue 2,2020, Pages 270-281, doi:10.20892/j.issn.2095-3941.2019.0420
4
Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling
Cancer Biology & Medicine, Volume 17, Issue 2,2020, Pages 418-432, doi:10.20892/j.issn.2095-3941.2019.0215
5
DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors
Cancer Biology & Medicine, Volume 17, Issue 2,2020, Pages 387-400, doi:10.20892/j.issn.2095-3941.2019.0380